349 related articles for article (PubMed ID: 28237084)
1. Identification and Profiling of Specialized Pro-Resolving Mediators in Human Tears by Lipid Mediator Metabolomics.
English JT; Norris PC; Hodges RR; Dartt DA; Serhan CN
Prostaglandins Leukot Essent Fatty Acids; 2017 Feb; 117():17-27. PubMed ID: 28237084
[TBL] [Abstract][Full Text] [Related]
2. Lipid Mediator Metabolomics Via LC-MS/MS Profiling and Analysis.
Dalli J; Colas RA; Walker ME; Serhan CN
Methods Mol Biol; 2018; 1730():59-72. PubMed ID: 29363065
[TBL] [Abstract][Full Text] [Related]
3. Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS.
Hartling I; Cremonesi A; Osuna E; Lou PH; Lucchinetti E; Zaugg M; Hersberger M
Clin Chem Lab Med; 2021 Oct; 59(11):1811-1823. PubMed ID: 34243224
[TBL] [Abstract][Full Text] [Related]
4. Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation.
Norris PC; Skulas-Ray AC; Riley I; Richter CK; Kris-Etherton PM; Jensen GL; Serhan CN; Maddipati KR
Sci Rep; 2018 Dec; 8(1):18050. PubMed ID: 30575798
[TBL] [Abstract][Full Text] [Related]
5. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue.
Colas RA; Shinohara M; Dalli J; Chiang N; Serhan CN
Am J Physiol Cell Physiol; 2014 Jul; 307(1):C39-54. PubMed ID: 24696140
[TBL] [Abstract][Full Text] [Related]
6. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
Serhan CN; Libreros S; Nshimiyimana R
Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
[TBL] [Abstract][Full Text] [Related]
7. Metabololipidomic profiling of functional immunoresolvent clusters and eicosanoids in mammalian tissues.
Norris PC; Serhan CN
Biochem Biophys Res Commun; 2018 Oct; 504(3):553-561. PubMed ID: 29524409
[TBL] [Abstract][Full Text] [Related]
8. Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling.
Elajami TK; Colas RA; Dalli J; Chiang N; Serhan CN; Welty FK
FASEB J; 2016 Aug; 30(8):2792-801. PubMed ID: 27121596
[TBL] [Abstract][Full Text] [Related]
9. Chiral chromatography-tandem mass spectrometry applied to the determination of pro-resolving lipid mediators.
Homann J; Lehmann C; Kahnt AS; Steinhilber D; Parnham MJ; Geisslinger G; Ferreirós N
J Chromatogr A; 2014 Sep; 1360():150-63. PubMed ID: 25124229
[TBL] [Abstract][Full Text] [Related]
10. Formation of lipoxins and resolvins in human leukocytes.
Kahnt AS; Schebb NH; Steinhilber D
Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106726. PubMed ID: 36878381
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and Changes in Lipid Mediator Profiling after Consumption of Specialized Pro-Resolving Lipid-Mediator-Enriched Marine Oil in Healthy Subjects.
Irún P; Carrera-Lasfuentes P; Sánchez-Luengo M; Belio Ú; Domper-Arnal MJ; Higuera GA; Hawkins M; de la Rosa X; Lanas A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003333
[TBL] [Abstract][Full Text] [Related]
12. Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: Concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake.
Calder PC
Biochimie; 2020 Nov; 178():105-123. PubMed ID: 32860894
[TBL] [Abstract][Full Text] [Related]
13. Regression of human coronary artery plaque is associated with a high ratio of (18-hydroxy-eicosapentaenoic acid + resolvin E1) to leukotriene B
Welty FK; Schulte F; Alfaddagh A; Elajami TK; Bistrian BR; Hardt M
FASEB J; 2021 Apr; 35(4):e21448. PubMed ID: 33749913
[TBL] [Abstract][Full Text] [Related]
14. Metabolipidomic profiling reveals an age-related deficiency of skeletal muscle pro-resolving mediators that contributes to maladaptive tissue remodeling.
Markworth JF; Brown LA; Lim E; Castor-Macias JA; Larouche J; Macpherson PCD; Davis C; Aguilar CA; Maddipati KR; Brooks SV
Aging Cell; 2021 Jun; 20(6):e13393. PubMed ID: 34075679
[TBL] [Abstract][Full Text] [Related]
15. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation.
Serhan CN; de la Rosa X; Jouvene C
J Intern Med; 2019 Sep; 286(3):240-258. PubMed ID: 30565762
[TBL] [Abstract][Full Text] [Related]
16. Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far?
Schebb NH; Kühn H; Kahnt AS; Rund KM; O'Donnell VB; Flamand N; Peters-Golden M; Jakobsson PJ; Weylandt KH; Rohwer N; Murphy RC; Geisslinger G; FitzGerald GA; Hanson J; Dahlgren C; Alnouri MW; Offermanns S; Steinhilber D
Front Pharmacol; 2022; 13():838782. PubMed ID: 35308198
[TBL] [Abstract][Full Text] [Related]
17. Maresin 1 induces a novel pro-resolving phenotype in human platelets.
Lannan KL; Spinelli SL; Blumberg N; Phipps RP
J Thromb Haemost; 2017 Apr; 15(4):802-813. PubMed ID: 28079976
[TBL] [Abstract][Full Text] [Related]
18. Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome.
Serhan CN; Dalli J; Colas RA; Winkler JW; Chiang N
Biochim Biophys Acta; 2015 Apr; 1851(4):397-413. PubMed ID: 25139562
[TBL] [Abstract][Full Text] [Related]
19. Chiral lipidomics of E-series resolvins: aspirin and the biosynthesis of novel mediators.
Oh SF; Vickery TW; Serhan CN
Biochim Biophys Acta; 2011 Nov; 1811(11):737-47. PubMed ID: 21712098
[TBL] [Abstract][Full Text] [Related]
20. Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid.
Beyer MP; Videla LA; Farías C; Valenzuela R
Nutrients; 2023 Jul; 15(15):. PubMed ID: 37571256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
